CELZ
NASDAQ · Biotechnology
Creative Medical Technology
$1.94
-0.03 (-1.52%)
Open$2.00
Previous Close$1.97
Day High$2.02
Day Low$1.93
52W High$6.25
52W Low$1.50
Volume—
Avg Volume22.7K
Market Cap7.32M
P/E Ratio—
EPS$-2.87
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,621.1% upside
Current
$1.94
$1.94
Target
$33.39
$33.39
$22.85
$33.39 avg
$43.53
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 28.1K | 56.5K | 749.0K |
| Net Income | -14,072,972 | -25,520,199 | -154,552 |
| Profit Margin | -49,940.7% | -47,443.7% | -20.6% |
| EBITDA | -14,431,357 | -27,623,995 | -155,667 |
| Free Cash Flow | — | — | -141,548 |
| Rev Growth | -50.4% | -50.4% | +1.8% |
| Debt/Equity | — | — | 0.17 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $217.49 | +2.05% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $351.85 | +0.82% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $139.37 | +2.22% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $446.54 | +0.76% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $772.64 | +3.12% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $330.87 | +4.68% | 139.7 | 43.84B |